1st Biotech IPO Since February: LB Pharma Upsizes Deal
LB Pharma is set to upsize its initial public offering, marking the 1st biotech listing since February and signaling potential renewed investor confidence.
LB Pharma is set to upsize its initial public offering, marking the 1st biotech listing since February and signaling potential renewed investor confidence.
A leading investment firm, S&P, has created a new values index fund. This fund is designed for evangelical investors looking to align their portfolio with faith.